Vol 2 Issue 4

IMMUNO-ONCOLOGY INSIGHTS

July 2021 Issue

Vol 2 Issue 4

Download PDF

Featuring

Issue Spotlight: Enhancing preclinical predictivity
Other articles

SPOTLIGHT

Enhancing preclinical predictivity
Christian Schmees
Guest Editor:
Christian Schmees at University of Tuebingen

Foreword

Enhancing preclinical predictivity: what is going wrong between preclinical <em>in vitro/in vivo</em> and clinical in vivo settings?

Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?

Christian Schmees
4 August 2021
Read

Editorial

Microphysiological systems for immuno-oncology: opportunities and challenges

Microphysiological systems for immuno-oncology: opportunities and challenges

Lucie A Low
5 August 2021
Read

Expert Insight

Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing

Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing

Michael Pawlak, Markus Templin, Christian Schmees
5 August 2021
Read

Interview

Recent evolution in the bispecific antibody and engineered cytokine fields

Recent evolution in the bispecific antibody and engineered cytokine fields

Raphael Clynes
5 August 2021
Read
Translational R&D insights for the allogeneic CAR T cell therapy field and beyond

Translational R&D insights for the allogeneic CAR T cell therapy field and beyond

Barbra Sasu
5 August 2021
Read

Expert Roundtable Video

Enhancing preclinical predictivity in I-O: what is going wrong between preclinical <em>in vitro/in vivo</em> and clinical settings?

Enhancing preclinical predictivity in I-O: what is going wrong between preclinical in vitro/in vivo and clinical settings?

P Ellmark, D Gilham, M Steegmaier et al.
5 August 2021
Watch

Expert Roundtable

Enhancing preclinical predictivity in I-O: what is going wrong between preclinical <em>in vitro/in vivo</em> and clinical settings?

Enhancing preclinical predictivity in I-O: what is going wrong between preclinical in vitro/in vivo and clinical settings?

5 August 2021
Read

Journal articles

FastFacts

T cell characterization in 3D cell models using advanced flow cytometry

T cell characterization in 3D cell models using advanced flow cytometry

Miniver Oliver
12 July 2021
Read